J&J sales higher

Published on .

Johnson & Johnson reported sales of $4.74 billion for the third quarter of 1995, an increase of 17.3% over the year-earlier quarter. Consolidated net earnings for the third quarter were $623 million, an increase of 18.7%. Worldwide consumer sales increased by 6.3%, which includes 0.4% in the U.S. and 12.7% internationally. The company said U.S. sales were flat due to softness in the Tylenol business as well as inventory contraction at some major retailers.

In this article:
Most Popular